Rockefeller Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Rockefeller Capital Management's HALO Position: Q3 2026 in Review
Rockefeller Capital Management increased its Halozyme (HALO) stake by 7.4% in Q3 2026, buying an estimated $57.7K and bringing the position to 8,708 shares worth $961K. The position accounts for ﹤0.01% of the portfolio, ranked #1769.
Rockefeller Capital Management first reported a position in HALO in Q4 2019 and has held it in 25 quarters since. The position peaked at $3.78M in Q3 2024. 774 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Rockefeller Capital Management held 8,708 shares of Halozyme worth $961K as of Q3 2026.
- Rockefeller Capital Management bought 597 Halozyme shares in Q3 2026, an estimated $57.7K.
- Halozyme made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #1769 holding.
- Rockefeller Capital Management first reported a position in Halozyme in Q4 2019 and has held it in 25 quarters since.
- Rockefeller Capital Management's Halozyme position peaked at $3.78M in Q3 2024.
- 774 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.